Still’s Disease Treatment Market, by Treatment (Pain Management, Corticosteroids, Tocilizumab, Canakinumab, Anakinra, and Others), by Route of Administration (Injectable and Oral), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Onlin

Still’s Disease Treatment Market, by Treatment (Pain Management, Corticosteroids, Tocilizumab, Canakinumab, Anakinra, and Others), by Route of Administration (Injectable and Oral), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Still’s disease, also known as adult-onset Still's disease (AOSD), is a rare type of inflammatory disorder associated with joint pain, rash, and fevers. This devastating condition may lead to long-term chronic arthritis and can result in permanent disabilities. Still's disease is related to the rash that does not itch and high spiking fever. This disorder can destroy affected joints, mainly the wrists. The treatment of Still’s disease involves medications that help inflammation.

Market Dynamics

The increase in funding for research and development to develop novel therapies and treatment coupled with increasing prevalence of Still’s disease are the major factors boosting growth of the global still’s disease treatment market. For instance, according to WebMD, Still's disease is more prevalent in women and affects less than 1 in 100,000 people across the globe develop Still's or adult-onset still’s each year.

Moreover, the emergence of drugs for the treatment of complications related to Still's disease is another factor propelling the market growth. For instance, in July 2020, the U.S. Food and Drug Administration (FDA) expanded the use of Canakinumab (Ilaris) for all patients with active Still's disease older than 2 years. Therefore, the drug can now be used for the adult-onset Still's disease (AOSD), which was previously approved for only juvenile-onset Still's disease.

However, the lack of healthcare finance in some low- and middle-income countries and patent expiration of drugs are some of the major factors restricting growth of the global still’s disease treatment market.

Key features of the study:

This report provides in-depth analysis of the global still’s disease treatment market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year

It elucidates potential revenue opportunity across different segments and explains the attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players

It profiles key players in the global Still’s disease treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies

Key players covered as a part of this study include F. Hoffmann-La Roche Ltd, Swedish Orphan Biovitrum AB, Novartis AG, Jubilant Life Sciences Ltd, AB2 Bio Ltd., Hikma Pharmaceuticals PLC, Dr Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan N.V., Zydus Cadila, Horizon Therapeutics plc, Amneal Pharmaceuticals LLC, Fresenius Kabi AG., and Vintage Labs

Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics

The global still’s disease treatment market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for Still’s disease treatment market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Still’s Disease Treatment Market, By Treatment:

Pain Management

Corticosteroids Therapy

Tocilizumab

Canakinumab

Anakinra

Others

Global Still’s Disease Treatment Market, By Route of Administration:

Injectable

Oral

Global Still’s Disease Treatment Market, By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Global Still’s Disease Treatment Market, By Region:

North America

By Country:

U.S.

Canada

By Treatment:

Pain Management

Corticosteroids Therapy

Tocilizumab

Canakinumab

Anakinra

Others

By Route of Administration:

Injectable

Oral

By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Europe

By Country:

U.K.

Germany

Italy

Spain

France

Russia

Rest of Europe

By Treatment:

Pain Management

Corticosteroids Therapy

Tocilizumab

Canakinumab

Anakinra

Others

By Route of Administration:

Injectable

Oral

By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Asia Pacific

By Country:

Australia

India

China

Japan

ASEAN

South Korea

Rest of Asia Pacific

By Treatment:

Pain Management

Corticosteroids Therapy

Tocilizumab

Canakinumab

Anakinra

Others

By Route of Administration:

Injectable

Oral

By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

By Treatment:

Pain Management

Corticosteroids Therapy

Tocilizumab

Canakinumab

Anakinra

Others

By Route of Administration:

Injectable

Oral

By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Middle East

By Country:

GCC

Israel

Rest of Middle East

By Treatment:

Pain Management

Corticosteroids Therapy

Tocilizumab

Canakinumab

Anakinra

Others

By Route of Administration:

Injectable

Oral

By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Africa

By Country/Region:

South Africa

Central Africa

North Africa

By Treatment:

Pain Management

Corticosteroids Therapy

Tocilizumab

Canakinumab

Anakinra

Others

By Route of Administration:

Injectable

Oral

By Distribution Channel:

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Company Profiles

F. Hoffmann-La Roche Ltd.

Company Overview

Product Portfolio

Financial Performance

Recent Highlights

Strategies

Swedish Orphan Biovitrum AB

Novartis AG

Jubilant Life Sciences Ltd

AB2 Bio Ltd.

Hikma Pharmaceuticals PLC

Dr Reddy's Laboratories Ltd.

Teva Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

Mylan N.V.

Zydus Cadila

Horizon Therapeutics plc

Amneal Pharmaceuticals LLC

Fresenius Kabi AG

Vintage Labs

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Treatment
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Technological Advancements in Still’s Disease Treatment
Key Developments
Acquisition, Collaborations & Partnerships
Epidemiology
Pipeline Analysis
Brand Analysis
4. Global Still’s Disease Treatment Market, Impact of Coronavirus (Covid-19) Pandemic
Pre-COVID situation
Post-COVID demand
Need for Still’s Disease Treatment
Recommendations and Guidelines by Regulatory Bodies
5. Global Still’s Disease Treatment Market, By Treatment, 2016 – 2027, (US$ Million)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Pain Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Tocilizumab
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Canakinumab
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Anakinra
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
6. Global Still’s Disease Treatment Market, By Route of Administration , 2016 – 2027, (US$ Million)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
7. Global Still’s Disease Treatment Market, By Distribution Channel, 2016 – 2027, (US$ Million)
Introduction
Market Share Analysis, 2020 and 2027 (%)
Y-o-Y Growth Analysis, 2017 – 2027
Segment Trends
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
8. Global Still’s Disease Treatment Market, By Region, 2016 – 2027, (US$ Million)
Introduction
Market Share Analysis, By Region, 2020 and 2027(%)
Y-o-Y Growth Analysis, By Region, 2017 –2027
Regional Trends
North America
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
GCC
Israel
Rest of Middle East
9. Competitive Landscape
Company Profiles
AB2 Bio Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
F. Hoffmann-La Roche Ltd
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Novartis AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Swedish Orphan Biovitrum AB
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Jubilant Life Sciences Ltd
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Vintage Labs
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Hikma Pharmaceuticals PLC
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Teva Pharmaceutical Industries Ltd
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Mylan N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Horizon Therapeutics plc
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Sun Pharmaceutical Industries Ltd
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Zydus Cadila
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Amneal Pharmaceuticals LLC
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Dr Reddy's Laboratories Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Fresenius Kabi AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
10. Section
References
Research Methodology
About us and Sales Contact
*Browse 26 market data tables and 28 figures on "Global Still’s Disease Treatment Market” - Forecast to 2027”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook